Two physicians argue that disaster preparedness for bioterrorist attacks diverts health care resources from other critical medical and public health needs.
A centralized registry to provide information to consumers regarding the effectiveness of clinical trials is needed to help patients make informed decisions about treatment.
Douglas E. Paull, MD, MS and Paul N. Uhlig, MD, MPA
Risk managers can help patient-subjects and clinician-researchers make informed novel device implantation decisions in the absence of preclinical trial data.
AMA J Ethics. 2020;22(11):E911-918. doi:
10.1001/amajethics.2020.911.
Derrel Zeno, Coreen Domingo, Anh Tran, Frank Martin, Kimberly O'Malley, Paul Haidet, Richard Street, and Carol Ashton
Community education about how patients can best communicate with their physicians has been successful in various communities, particularly when working with an ethnically diverse patient population.